HA Sustainable Infrastructure Capital enters its next earnings print on June 3 with a tightening gap between analyst conviction and the stock's still-elevated short base — a setup that rewards clarity on both credit quality and clean energy deal flow.
The analyst community has turned notably more constructive over the past three weeks. Morgan Stanley raised its price target to $57 just this week, maintaining Overweight, and follows similar moves from JP Morgan ($50), UBS ($50), Wells Fargo ($46), and RBC Capital ($48), all post-earnings upgrades from the first half of May. The consensus mean target is now $48.93 against a close of $41.21, implying roughly 19% upside. Every recent change has been a raise, not a cut. With the forward EPS growth score ranking in the 93rd percentile and EPS momentum over 30 and 90 days also running well above average, the Street is repricing future earnings rather than simply ratcheting multiples. The P/E multiple is 13.2x, down slightly over a month even as targets have climbed — suggesting the earnings upgrade cycle is doing the work, not price.
The short side tells a different story. Short interest is running at nearly 10% of free float, a level that has been remarkably stable over the past six weeks — ranging between 9.8% and 10.1% with no decisive reduction. The ORTEX short score is elevated at 72.0, placing the stock in the 4th percentile by short score rank — meaning 96% of the universe carries less short pressure. Despite that positioning, the lending market is relaxed. Availability is at 214%, comfortably above its 52-week low of 203% — there is more than twice as much stock available to borrow as there is currently short. Cost to borrow has eased to 0.47% this week after briefly touching 0.58% last week. The shorts are present, but they are not facing any squeeze pressure; the borrow market is open and cheap.
Options sentiment has shifted slightly more cautious over the past two weeks. The put/call ratio is running at 0.39, about 1.4 standard deviations above its 20-day average of 0.33. That is a modest defensive tilt rather than a dramatic hedge — the PCR's 52-week low is 0.30 and its high is 3.07, so the current reading sits well inside the lower quartile of historic readings. Investors are incrementally buying more downside protection, but this is not a panicked setup ahead of the June 3 print.
The last earnings report, released May 7, landed hard. The stock fell 5.2% the next day and 4.4% over the following week — a notably negative immediate reaction even as analysts subsequently raised targets. That divergence is worth watching: the market sold the print while the Street upgraded on the details. Whether June 3 reproduces that pattern or whether analyst conviction now acts as a floor is the central tension heading into the event.
Insider activity adds a mild overhang worth noting. Chairman Jeff Eckel sold roughly 134,400 shares in February for approximately $5.3 million, the most significant insider transaction in the recent record. Smaller routine sales from the Chief Accounting Officer appeared in both March and May. Net insider activity over the past 90 days is a net sale of around 138,000 shares at an estimated $5.4 million value. None of these trades carry high significance scores, and the chairman's February sale was likely part of a pre-arranged plan, but the directional signal is tilted toward selling — a counterweight to the bullish analyst tone.
With the June 3 print approaching, the question is less about whether growth targets hold and more about whether management's commentary on deal pipeline and credit spreads can close the gap between a $41 stock and a $49 consensus target — particularly against a short base that has shown no inclination to cover.
See the live data behind this article on ORTEX.
Open HASI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
